KRTAP5-8

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, KRTAP5-8 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated KRTAP5-8 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher KRTAP5-8 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated KRTAP5-8 expression acts as an unfavorable survival marker.

SKCM and LUAD are the cancer types where KRTAP5-8 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
SKCMOSMedianII,III,IV0.1380.846<.00119view →
LUADOSMedianAll0.2280.788.00318view →
Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

KRTAP5-8–SKCM (OS)

Kaplan–Meier survival curve for KRTAP5-8 mutant vs wild-type samples in SKCM.

Open the SKCM breakdown →

Exploration